Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture.

We observed previously in vitro that the cytotoxicity of bleomycin (BLM), an anticancer drug in current use, was greatly potentiated by exposing cultured cells to appropriately chosen electric pulses. We then showed in vivo, on tumor-bearing mice, that the same electric pulses also potentiated the antitumoral activity of BLM. In the present work, we demonstrate on DC-3F cells in vitro, that this potentiation is closely related to cell electropermeabilization and the consequent direct internalization of BLM molecules in the cytosol. The survival response curve (SRC) of the electropermeabilized (EP) cells exposed to BLM (plotted as logarithm of survival versus external drug concentration) shows a linear pattern usual for the SRCs of intact cells exposed to current cytotoxic drugs, though in the nanomolar range of concentrations. We have succeeded in determining the relation between BLM cytotoxicity on EP cells and the number of electroloaded BLM molecules per cell (that is the average number, per cell, of BLM molecules internalized into the cytosol). We conclude that (1) BLM molecules possess very intense cytotoxic activity which in non-EP cells is drastically limited by the intact plasma membrane; and (2) in these intact cells, the plasma membrane is responsible for the unusual upward concave curvature of the SRC resulting from exposure to BLM.

[1]  L. Mir,et al.  Stable [57Co]-bleomycin complex with a very high specific radioactivity for use at very low concentrations. , 1990, Biochemical and biophysical research communications.

[2]  T. Takeuchi,et al.  New antibiotics, bleomycin A and B. , 1966, The Journal of antibiotics.

[3]  S. Koike,et al.  The effect of bleomycin on survival and tumor growth in a C3H mouse mammary carcinoma. , 1973, Cancer research.

[4]  R. Humphrey,et al.  The effects of bleomycin on survival and cell progression in Chinese hamster cells in vitro. , 1971, Cancer research.

[5]  J. L. Biedler,et al.  Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. , 1970, Cancer research.

[6]  C. Bailly,et al.  Plasma membrane perturbations of KB3 cells induced by the bleomycin-iron complex. , 1990, Cancer research.

[7]  J. Weaver,et al.  The number of molecules taken up by electroporated cells: quantitative determination , 1989, FEBS letters.

[8]  M. Watanabe,et al.  Effect of bleomycin on mammalian cell survival. , 1972, Journal of the National Cancer Institute.

[9]  D. Petering,et al.  Properties of the initial reaction of bleomycin and several of its metal complexes with Ehrlich cells. , 1986, Cancer research.

[10]  J. Lazo,et al.  Chemical modulation of bleomycin induced toxicity. , 1986, International journal of radiation oncology, biology, physics.

[11]  P. Lin,et al.  Effects of iron, copper, cobalt, and their chelators on the cytotoxicity of bleomycin. , 1983, Cancer research.

[12]  T. Takeuchi,et al.  Liblomycin, a new analogue of bleomycin. , 1987, Cancer treatment reviews.

[13]  B Deuticke,et al.  Formation and properties of aqueous leaks induced in human erythrocytes by electrical breakdown. , 1985, Biochimica et biophysica acta.

[14]  D. Sem,et al.  Intracellular DNA strand scission and growth inhibition of Ehrlich ascites tumor cells by bleomycins. , 1990, Cancer research.

[15]  U. Zimmermann,et al.  Electric field-mediated fusion and related electrical phenomena. , 1982, Biochimica et biophysica acta.

[16]  G. A. van der Marel,et al.  Site-specific cleavage of RNA by Fe(II).bleomycin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Mir,et al.  Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. , 1988, Experimental cell research.

[18]  S. Horwitz,et al.  Characterization of the association of radiolabeled bleomycin A2 with HeLa cells. , 1984, Cancer research.

[19]  T. Tsong,et al.  Formation and resealing of pores of controlled sizes in human erythrocyte membrane , 1977, Nature.

[20]  Y. Uehara,et al.  Specificity of transport of bleomycin and cobalt-bleomycin in L5178Y cells. , 1982, Biochemical and biophysical research communications.

[21]  F. L. Crane,et al.  Bleomycin control of transplasma membrane redox activity and proton movement in HeLa cells. , 1985, Biochemical pharmacology.

[22]  M. Smerdon,et al.  Bleomycin-induced DNA damage and repair in human cells permeabilized with lysophosphatidylcholine. , 1990, Cancer research.

[23]  L. Mir,et al.  Electrochemotherapy of spontaneous mammary tumours in mice. , 1991, European journal of cancer.

[24]  J. Stubbe,et al.  Mechanisms of bleomycin-induced DNA degradation , 1987 .

[25]  L. Mir,et al.  Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. , 1988, Biochemical pharmacology.

[26]  L. Mir,et al.  Voltage-dependent introduction of a d[α]octothymidylate into electropermeabilized cells , 1989 .

[27]  S. Akiyama,et al.  Control of permeation of bleomycin A2 by polyene antibiotics in cultured Chinese hamster cells. , 1979, Cancer research.

[28]  L. Mir,et al.  Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. , 1991, European journal of cancer.

[29]  S. Mizuno.  Ethanol-induced cell sensitization to bleomycin cytotoxicity and the inhibition of recovery from potentially lethal damage. , 1981, Cancer research.

[30]  J. Teissié,et al.  Reversible plasma membrane ultrastructural changes correlated with electropermeabilization in Chinese hamster ovary cells. , 1988, Biochimica et biophysica acta.